Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations

研究成果: 雜誌貢獻文章同行評審

16 引文 斯高帕斯(Scopus)

指紋

深入研究「Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations」主題。共同形成了獨特的指紋。